Search

A recent study conducted in Orebro, Sweden, explored the effectiveness of Botulinum toxin Type A (BTX-A) injections in managing jaw myalgia. The research, funded by various organizations, found that a single session of BTX-A injections did not significantly reduce functional jaw pain compared to a placebo. The study suggests that further research with a larger sample size may be needed to determine the efficacy of BTX-A in treating jaw myalgia. [Extracted from the article]

A recent report from the University of Orebro in Sweden discusses the use of serum proteomics to characterize the heterogeneity of Inflammatory Bowel Disease (IBD). The study aimed to identify discriminative patterns of biological subtypes across multiple European cohorts by measuring inflammation-related serum proteins in IBD patients and healthy controls. The findings suggest a continuous IBD spectrum rather than a clear separation between Crohn's disease and ulcerative colitis, with disease location potentially reflecting more similarity than the traditional CD versus UC classification. [Extracted from the article]